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Abstract 
Background: The histological diagnosis of autoimmune pancreatitis (AIP) by an endoscopic ultrasound (EUS)-guided 
approach is still challenging.
Methods: We investigated the utility of the 21-gauge Menghini-type biopsy needle with the rolling method for the 
histological diagnosis of AIP, in comparison with conventional 22-gauge needles. Among total 28 patients, rate of 
definitive histological diagnosis, acquired sample area of tissue, rate of histopathological diagnosis of AIP, and adverse 
events were retrospectively analyzed.
Results: Definitive histological diagnoses were successfully accomplished in all 14 patients (100%) treated with a 
Menghini-type needle, and in 57% of cases (8/14) treated with conventional 22-gauge needles (P < 0.001). The median 
sample area of the tissue, except for blood contamination, was remarkably larger by the Menghini-type needle than 
by conventional-type needles (6.2 [IQR, 4.5–8.8] versus 0.7 [IQR, 0.2–2.0]  mm2, P < 0.001), and the area per punctures 
was approximately 4 times larger (1.4 [IQR: 0.9–2.9] versus 0.3 [IQR: 0.1–0.6]  mm2/puncture, P < 0.001). Based on the 
International Consensus Diagnostic Criteria, lymphoplasmacytic infiltration, abundant IgG4-postive cells, storiform 
fibrosis, and obliterative phlebitis were found in 86%/29%, 64%/0%, 36%/0%, and 7%/0% patients who were treated 
with the Menghini-type needle and conventional-type needles, respectively. Consequently, histopathological diag-
nosis with type 1 AIP (lever 1 or 2) was achieved in 9 patients (64%) treated with the Menghini-type needle and in no 
patient treated with conventional-type needles (P < 0.001). Two patients who had mild post-procedural pancreatitis 
improved with conservative treatment, and no bleeding occurred in patients treated with the Menghini-type needle.
Conclusion: EUS-guided rolling method with the 21-gauge Menghini-type biopsy needle is useful for the histo-
pathological diagnosis of AIP, due to its abundant acquisition of good-quality tissue from the pancreas.
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Background
Autoimmune pancreatitis (AIP) is an unusual type of 
pancreatitis, diagnosed using five criteria (parenchy-
mal imaging, ductal imaging, serology, histology of the 
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pancreas, and response to steroids) according to the 
International Consensus Diagnostic Criteria (ICDC) [1, 
2]. In clinical practice, the definitive diagnosis of AIP is 
sometimes difficult due to a lack of diagnostic evidence 
based on noninvasive pancreatic imaging and serology, 
especially for patients with segmental or focal pancreatic 
enlargement. Therefore, histological findings are crucial 
for the diagnosis of type 1 AIP, whose defining feature 
is lymphoplasmacytic sclerosing pancreatitis (LPSP), as 
well as type 2 AIP, whose defining feature is idiopathic 
duct-centric pancreatitis (IDCP). However, the ICDC 
states that histological assessments should be performed 
using only surgical or core biopsy specimens, which 
require an invasive procedure [3].
Endoscopic ultrasound-guided fine-needle aspiration 
(EUS-FNA) is standardly performed for the diagnosis of 
solid pancreatic masses [4–6], and the advent of a dedi-
cated needle has improved the rate of sufficient tissue 
sampling [7–10]. Several reports have found that an EUS-
guided fine-needle biopsy (EUS-FNB) and EUS-FNA 
using a 19-gauge trucut needle and 19- and 22-gauge 
conventional FNA or FNB needles were feasible and safe 
for obtaining pancreatic tissue specimens for the diag-
nosis of AIP [11–21]. Recently, Notohara et al. reported 
an extremely important point that EUS-FNB with large 
tissue amounts was useful for diagnosing type 1 AIP, 
notably by facilitating successful IgG4 immunostain-
ing [22]. From that perspective, further improvement is 
still needed in order to obtain greater good-quality tissue 
samples for evaluating distinctive histological findings of 
AIP.
The 21-gauge Menghini-type biopsy needle is a 
newly developed needle for EUS-FNB that was recently 
reported to provide high-quality specimens for histo-
logical evaluations for the diagnosis of solid pancreatic 
masses, especially in terms of both sample cellularity and 
blood contamination, compared with a 22-gauge conven-
tional needle [23, 24]. The two special features of this nee-
dle, namely the tapered beveled-edge of the outer needle 
and the inner needle connected to a barrel equipped 
with an aspiration piston, can substantially improve the 
acquisition of ample tissue with little blood contamina-
tion. However, in the field of liver biopsies, a unique 
technique has long been applied wherein the needle is 
quickly punctured into the target lesion, turned around 
once or twice and then removed in order to wrench out 
core tissue [25]. This technique is referred to as the “roll-
ing method” in the present study. In our ex vivo test, the 
Menghini-type needle was found to be the easiest of the 
needles we evaluated to rotate through the channel of the 
endoscope. Therefore, we hypothesized that the combi-
nation of these strengths would improve the histological 
diagnostic ability of AIP.
In the present study, we clarified the utility of this 
21-gauge Menghini-type biopsy needle combined with 
the “rolling method” for the histological diagnosis of AIP.
Methods
Study design
This was a retrospective, single-center study conducted 
at Fukuyama City Hospital in Japan. The study was per-
formed under the approval of the ethics committees of 
the hospital.
Patients
Between January 2010 and November 2018, 49 patients 
were ultimately diagnosed with AIP according to the 
ICDC. Among them, cytological and histological assess-
ments by EUS-FNA and EUS-FNB were performed in 41 
patients.
During the early period (January 2010 to September 
2015), several different types of conventional FNA or 
FNB needles, such as the EchoTip ultra (COOK Japan, 
Tokyo, Japan), Expect (Boston Scientific Japan, Tokyo, 
Japan), SonoTip Procontrol (Medi-Globe GmbH, Rosen-
heim, Germany), and EchoTip ProCore (COOK), were 
used. In the later period (October 2015 to November 
2018), a 21-gauge Menghini-type needle (EUS Sonopsy 
CY; Hakko Medical, Nagano, Japan) and a 22-gauge Fran-
seen-type needle (Acquire; Boston Scientific) were used 
for these procedures. The selection of these devices for 
use was dependent on the period and the endoscopists’ 
preference.
Of note, 5 patients treated using 25-gauge conven-
tional FNA needles were excluded due to low likelihood 
of acquiring adequate tissue, and 5 patients treated with 
the Franseen-type needle, 2 treated with the EchoTip 
ProCore and 1 treated with the 19-gauge needle were 
excluded due to the small number of patients. Therefore, 
a total of 28 patients were included in this study: the 14 
patients treated with the 21-gauge Menghini-type needle 
and the 14 patients treated with 22-gauge conventional 
needles as a historical control.
EUS‑FNA and EUS‑FNB procedures
A linear echoendoscope (UCT-260; Olympus, Tokyo, 
Japan) was used for EUS-FNA and EUS-FNB. These 
procedures were performed by mainly two experienced 
endoscopists under conscious sedation with midazolam 
and pethidine.
For patients with diffuse pancreatic enlargement, punc-
ture was performed mainly via the transgastric route 
because of its technical ease [26, 27]. For patients with 
segmental or focal pancreatic enlargement, puncture was 
performed via the transgastric or transduodenal route, 
depending on the location.
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Figure  1 shows the 21-gauge Menghini-type needle 
(EUS Sonopsy CY), which was originally made for per-
forming liver biopsies (Sonopsy C1; HAKKO Medical) 
[23, 24, 28]. This needle has two features of note. First, 
the tapered shape of the beveled-edge can facilitate 
obtaining adequate core tissue with just a few strokes. 
Second, unlike other FNA and FNB needles, keeping 
the inner needle attached to the plunger of the syringe 
within the outer needle during aspiration helps obtain 
high-quality tissue without crushing. After positioning at 
the intended puncture site, the outer barrel was quickly 
moved forward until the puncture needle was slightly 
inserted into the intended site. For aspiration, the piston 
of a 10-ml syringe was drawn until it was locked without 
removal of the inner needle (stylet). Following aspiration 
for at least 3 s to allow negative pressure to accumulate 
at the tip, the needle was pushed forward through the 
intended site, and then, in order to wrench out core tis-
sue, we additionally turned the outer barrel until the 
tip of the needle was confirmed to have been rotated 
simultaneously within the lesion in the EUS view, just as 
in the liver biopsy technique [25] known as the “rolling 
method”. This procedure was repeated only two or three 
times in order to reduce the risk of contamination with 
blood induced by performing too many strokes, and then 
the needle was removed.
As the conventional EUS-FNA, the 22-gauge needles 
were punctured at the target lesion, and the stylets were 
removed. The needles were then moved back and forth 
within the lesion with negative pressure 15–20 times per 
puncture before being removed. In addition, the fanning 
technique was used for all 28 patients.
After performing EUS-FNA and EUS-FNB, endoscopic 
retrograde pancreatocholangiography (ERCP) was basi-
cally performed in a single-session [29–31] to achieve 
pancreatographic imaging and biliary drainage if patients 
had obstructive jaundice.
On‑site evaluations
All samples were first assessed for cellular adequacy by 
cytopathologists using Papanicolau staining. After ade-
quate cellularity for cytology had been confirmed, the 
remaining and additional samples were preserved for 
histological evaluations. At that time, endoscopists tried 
to identify whitish core tissue on a glass slide, which was 
so-called “MOSE” (macroscopic on-site quality evalu-
ation) [32], and the procedure was performed up to six 
punctures.
Pathological evaluations
Two pathologists, who blinded to the type of needle, per-
formed cytological and histological evaluation. A benign 
or malignant status was cytologically determined. As a 
histological evaluation, formalin-fixed paraffin-embed-
ded tissue was stained with hematoxylin–eosin (H&E) 
and IgG4. In addition, obliterative phlebitis (OP) was 
diagnosed by Elastica van Gieson staining. According to 
the ICDC, the LPSP findings (marked lymphoplasma-
cytic infiltration, OP, storiform fibrosis [SF], abundant 
IgG4-positive plasma cells [> 10 cells/high-power field 
{HPF}]) and the IDCP findings (granulocytic infiltration 
of duct wall [GEL], and absent or scant IgG4-positive 
cells) were evaluated. Based on these findings, level 1 and 
2 criteria were adopted for the diagnosis of AIP.
In addition, the total area of the acquired tissue, except 
for mucus or blood contamination, was accurately meas-
ured under a photomicroscope (microscope, BX53, 
Olympus, Tokyo, Japan; camera, DP73, Olympus) using 
imaging software (cellSens, standard 1.8.1, Olympus).
Study outcomes
As a primary outcome, success rate of confirming his-
tological diagnosis, such as AIP and pancreatitis due to 
chronic inflammation, was evaluated. As secondary out-
comes, the amount of the acquired tissue, the histological 
findings, cytological diagnosis, and adverse events were 
also assessed. The amount of the acquired tissue was 
defined as the total area of the acquired tissue measured 
by the imaging software, as described above. Histologi-
cal findings and cytological diagnosis were assessed, as 
described in the Pathological evaluations. Adverse events 
and their severity related to the procedures were defined 
and graded according to ASGE lexicon [33].
Statistical analyses
Continuous data are presented as medians with the range 
or interquartile range (IQR). Continuous variables and 
frequency distribution were compared with the Mann–
Whitney U test and Fisher’s exact or χ2 test, respectively. 
A P-value < 0.05 was considered statistically significant. 
All statistical analyses were performed with the Graph-
Pad Prism software program, ver. 6.0 (GraphPad Soft-
ware, San Diego, CA, USA).
Results
Patients’ characteristics
Table 1 summarizes the characteristics of the 28 included 
patients. In this study, 14 patients each were managed 
using a Menghini-type needle with the rolling method 
and conventional-type needles. The ratio of male-to-
female patients was approximately 4:1 in both groups. 
Based on the ICDC, the diagnosis of definitive type 1 
AIP was obtainable in 23 patients (82%) but no patients 
had type 2 AIP before histological evaluation. No pan-
creatic lesions developed malignancy during over 3-years 
follow-up.
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Fig. 1 A 21-gauge Menghini-type needle. a Whole image of the 21-gauge endoscopic ultrasound-guided fine needle aspiration biopsy needle 
(EUS Sonopsy CY). b, c Image of the needle tip before (upper) and after (lower) aspiration using the piston, respectively. d After puncture with 
aspiration under 10 mL of negative pressure, the handle of the needle was turned until the tip of the needle was confirmed to be rotated in the 
lesion. To reduce the contamination of blood, this procedure was repeated only three times, and the needle was removed
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Clinical findings of the enrolled patients
As shown in Table 1, segmental or focal enlargement of 
the pancreas was more common in patients treated with 
conventional-type needles than in those treated with 
Menghini-type needles (n = 7 [50%] and n = 3 [21%], 
respectively; not significant). However, a focal lesion 
of the pancreas head alone, which required a transduo-
denal approach for EUS-FNB, was detected in 1 (7%) 
in both groups. Elevated serum IgG4 levels (≥ 135  mg/
dl) were seen in 75% of patients in both groups. Steroid 
administration was conducted in 25 patients (89%) and 
was effective in all, while the remaining 3 patients showed 
improvement of pancreatic enlargement without steroid 
therapy within 6 months.
Success rate of confirming histological diagnosis 
and acquired tissue area by EUS‑FNB
Definitive histological diagnoses were successfully 
achieved in all patients treated with a Menghini-type 
biopsy needle, with a median of 4 (IQR: 3–5) punctures 
Table 1 Patients’ characteristics and clinical findings
ICDC International Consensus Diagnostic Criteria, AIP Autoimmune pancreatitis, MPD Main pancreatic duct
a Remaining three patients improved before introduction of treatment with steroids
Menghini‑type Conventional‑type P value
(N = 14) (N = 14)
Male (n [%]) 11 (71) 12 (86) 0.622
Age (years, median [range]) 71 (50–79) 62 (54–75) 0.018
Obstructive jaundice (n [%]) 4 (29) 4 (29) 1.000
HbA1c (%, median [range]) 7.3 (5.2–11.7) 5.8 (5.1–8.7) 0.032
Diagnosis using the ICDC without histological findings of EUS-guided approach (n [%])
 Definitive type 1 AIP 13 (93) 10 (71) 0.139
 Not definitive type 1 AIP 1 (7) 4 (29)
 Type 2 AIP 0 0
Median follow-up period (days [range]) 1116 (297–3303) 1747(683–3303) 0.028
Pancreatic imaging
 Enlargement with delayed enhancement
 Diffuse/Segmental or Focal 11/3 7/7 0.052
 MPD narrowing
 Long (≥ 1/3) or multiple/Segmental or Focal 11/2 6/4 0.115
 Location of the enlarged part 0.412
 Whole 8 (57) 7 (50)
 Head 1 (7) 1 (7)
 Body 0 1 (7)
 Tail 0 2 (14)
 Head and body 0 1 (7)
 Body and tail 3 (21) 1 (7)
 Head and tail 2 (14) 1 (7)
Serology
 IgG4 (mg/dl, median [range]) 364.3 (104–1090) 267 (32–1270) 0.828
 IgG4 ≥ 135 mg/dl (N [%]) 11 (79) 11 (79) 1.000
 Level 1, ≥ 270 mg/dl 9 (64) 7 (50)
 Level 2, ≥ 135 mg/dl but < 270 mg/dl 2 (14) 4 (29)
Other organ involvement
 Sclerosing cholangitis 5 (36) 6 (43) 0.699
 Retroperitoneal fibrosis 4 (29) 3 (21) 0.663
 IgG4-related kidney disease 3 (21) 0 0.067
 Sialadenitis 2 (14) 0 0.142
 Dacryoadenitis 1 (7) 0 0.309
 Inflammatory bowel disease 0 0 –
Response to steroids (n [%]) 14 (100) 11a (100) –
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(Table  2). In contrast, conventional-type needles 
obtained the diagnosis in 57% of cases (8/14), with a 
median of 3 (IQR: 1–4) punctures.
Regarding the sample area of the acquired tissue, the 
median sample area was significantly larger by a Meng-
hini-type needle than by conventional-type needles (6.2 
[IQR, 4.5–8.8] versus 0.7 [IQR, 0.2–2.0]  mm2, P < 0.001) 
(Fig.  2, 3, 4). In addition, the area per punctures was 
approximately 4 times larger by a Menghini-type needle 
than by conventional-type needles (1.4 [IQR: 0.9–2.9] 
versus 0.3 [IQR: 0.1–0.6]  mm2/puncture, P < 0.001). In 
contrast, the stroke lengths of the needles were not sig-
nificantly different between the two approaches. Taken 
together, these findings show that using the 21-gauge 
Menghini-type needle with the rolling method was 
a considerably superior approach to using conven-
tional 22-gauge needles for histological evaluations, 
resulting in obtaining abundant tissue with little blood 
contamination.
Histological findings by EUS‑FNB
Regarding the histopathological findings based on the 
ICDC, lymphoplasmacytic infiltration, abundant IgG4-
postive cells, SF, and OP were found by a Menghini-
type needle in 12 (86%), 9 (64%), 5 (36%), and 1 (7%) 
patients, respectively (Table  2, Fig.  5). Consequently, 9 
patients (64%) were histopathologically diagnosed with 
AIP (level 1 and 2 criteria of LPSP met by 5 [36%] and 
4 [29%] patients, respectively). This histological finding 
Table 2 Results Associated with EUS-FNA and EUS-FNB
IQR interquartile range, HPF high-power field
Menghini‑type 21‑gauge Conventional‑type 22‑gauge P value
N = 14 N = 14
Needles Sonopsy 14 Expect 7
Sonotip 4
EchoTip 3
Route for puncture 0.231
 Transgastric 12 (86) 8 (57)
 Transduodenal 1 (7) 4 (29)
 Transgastric and transduodenal 1 (7) 2 (14)
Number of punctures (median [IQR]) 4 (3–5) 3 (1–4) 0.016
Stroke length of needles (median [IQR]) 1.6 (1.5–2.0) 1.5 (1.5–1.9) 0.664
Successful confirmation of histological diagnosis (n [%]) 14 (100) 8 (57) 0.006
A confirmed cytological diagnosis of no malignancy (n [%]) 14 (100) 12 (86) 0.142
Adverse events (n [%]) 2 (14) 0 0.142
Histological findings
 Periductal lymphoplasmacytic infiltrate without granulocytic infiltration 12 (86) 4 (29) 0.002
 Obliterative phlebitis 1 (7) 0 0.310
 Storiform fibrosis 5 (36) 0 0.014
 Abundant (> 10 cells/HPF) IgG4-positive cells 9 (64) 0  < 0.001
Histological diagnosis for AIP  < 0.001
 Level 1 5 (36) 0
 Level 2 4 (29) 0
Fig. 2 Comparison of the amount of acquired tissue area measured 
by imaging software “cellSens®”. a The median acquired sample area 
of the tissue, except for that with blood contamination, was markedly 
larger with the Menghini-type needle than with conventional-type 
needles (6.2 [IQR, 4.5–8.8] versus 0.7 [IQR, 0.2–2.0]  mm2, P < 0.001). b 
The median sample area per punctures was approximately 4 times 
larger (1.4 [IQR: 0.9–2.9] versus 0.3 [IQR: 0.1–0.6]  mm2/puncture, 
P < 0.001)
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contributed to a diagnosis of definitive type 1 AIP in a 
patient who had not been confirmed to have definitive 
type 1 AIP. On the other hand, conventional-type needle 
did not provide any diagnosis of AIP without detectable 
abundant-IgG4-postive cells, though lymphoplasmacytic 
infiltration was seen in only 29% of cases (4/14).
Confirmed cytological diagnoses of no malignancy 
by EUS‑FNA
The cytological diagnosis for distinguishing between 
malignant and benign cases was successfully confirmed 
in all patients treated with a Menghini-type needle and 
in 86% (12/14) of those treated with a conventional-type 
needle (not significant) (Table  2). The inability to make 
an accurate diagnosis was attributed to the acquisition of 
only a few cells showing degradation and the difficulty of 
performing a puncture due to the hardness of the pancre-
atic mass.
Adverse events
Two patients (14%) treated with a Menghini-type needle 
with the rolling method had mild pancreatitis (Table 2). 
Fig. 3 Pancreatic tissue obtained by the 21-gauge Menghini-type needle with the rolling method. a A macroscopic image shows abundant 
whitish tissue with little blood contamination. b–f Microscopic images of the tissue with hematoxylin–Eosin (HE) staining are shown among five 
representative cases. Exceedingly long, high-quality pancreatic tissues can be acquired by this procedure
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These patients had been punctured six times (transgas-
tric and transuduodenal routes three times) in one and 
five times (transgastric route) in the other for the EUS 
procedure. Both patients had also undergone essential 
therapeutic-ERCP in a single session to achieve biliary 
drainage with pancreatographic imaging. These mild 
pancreatitis improved immediately with conservative 
therapy. No bleeding occurred in either group.
Discussion
In this study, the 21-gauge Menghini-type biopsy nee-
dle with the rolling method was superior to the conven-
tional 22-gauge FNA needles in terms of the histological 
diagnosis of AIP. We clearly demonstrated the reason 
was that the Menghini-type biopsy needle obtained 
remarkably large tissue by measurement of sample area 
of acquired tissue. Thus, definitive histological diagnosis 
was achieved in all 14 patients and the histological diag-
nosis of type 1 AIP was confirmed in 64% of them accord-
ing to the ICDC, by EUS-FNB using the Menghini-type 
biopsy needle with the rolling method.
The ICDC published in 2011 do not recommend EUS-
FNA or EUS-FNB for the histological diagnosis of AIP, as 
the findings are inconclusive [2]. However, developments 
in EUS-FNA technology have improved the EUS-FNB-
based assessment of several pancreatic masses, including 
pancreatic cancer, pancreatic neuroendocrine tumors, 
and AIP. Previous published articles on the histologi-
cal diagnosis for AIP by EUS-FNB were summarized in 
Table 3. The first of such reports described an EUS trucut 
biopsy with a 19-gauge trucut needle as a safe and accu-
rate procedure for preserving the tissue architecture and 
aiding in the diagnosis of AIP [11, 12]. Also, a 19-gauge 
FNA needle provided a high rate of successful histologi-
cal evaluations [14]. However, these needles are quite 
difficult to be handled under scope angulation and be 
punctured within the pancreatic mass of the head via 
the trasduodenal route [4, 11, 12, 26, 27], and an ex vivo 
study revealed that both 19-gauge needles induced 
greater resistance than 22- and 25-gauge needles for 
EUS-FNA [27], suggesting that these 19-gauge needles 
might be restricted to use by experts because of the han-
dling difficulty.
Regarding the use of 22-gauge FNA needles for histo-
logical evaluations for the diagnosis of AIP, three pro-
spective studies have been already conducted. Kanno 
et  al. reported that pancreatic tissues with more than 
1 HPF were obtained in 80% (62/78) of patients, and 
AIP with an ICDC level of 1 or 2 was diagnosed in 58% 
(45/78) of the patients [17]. Cao et al. also reported that 
adequate tissue for histological evaluation was obtained 
in 93% (25/27), AIP with an ICDC level of 1 or 2 was 
diagnosed in 63% (17/27) of the patients and even head 
lesions were successfully punctured by a 22-gauge nee-
dle in the majority of patients (89%; 24/27) [19]. On the 
other hand, Morishima et al. reported that 22-gauge nee-
dles provided no patient with AIP with an ICDC level 
1, and were not effective for the diagnosis of AIP due to 
the difficulty of obtaining pathological findings meeting 
three or more of the LPSP items [18]. A previous report 
comparing pancreatic biopsy specimens and surgically 
resected specimens showed that pancreatic specimens 
by core biopsy provided adequate histologic findings for 
AIP in only 22% of cases (2/9), whereas surgical speci-
mens almost always provided sufficient findings for mak-
ing a diagnosis [34]. In addition, the patchy distribution 
of specific histological findings, such as LPSP [35–37] 
and infiltration of IgG4-positive plasma cells [38] and 
the different severities [34] can affect the detection rate 
of histological findings. These data indicate that 22-gauge 
Fig. 4 Pancreatic tissue obtained by a conventional 22-gauge needle. a A microscopic image of Hematoxylin–Eosin (HE) staining shows a rather 
small amount of tissue with substantial fibrin and neutrophils. This tissue proved insufficient for a histological evaluation (yellow ellipse). This case 
was identical to that in Fig. 3b. b A microscopic image of HE staining shows a rather small amount of tissue with substantial blood. This tissue 
proved insufficient for a histological evaluation (yellow rectangle). This case was identical to that in Fig. 3c
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conventional FNA needles ensure relatively stable tissue 
collection but the amount of obtained specimen is not 
always sufficient for the histological diagnosis of AIP.
Recently, this 21-gauge Menghini-type biopsy needle 
was reported to be more useful for achieving the histo-
pathological diagnosis of solid pancreatic masses than a 
standard 22-gauge needle [23, 24]. The most important 
feature of this needle is the equipment of an inner needle 
with plunger. Keeping the inner needle inside the outer 
needle during suction improves the ability to obtain 
adequate core tissue with preservation of a non-crushed 
tissue architecture. Indeed, this report revealed that the 
use of this needle was strongly associated with high cel-
lularity (OR = 2.99, 95% CI 0.96–9.74, P = 0.062) and low 
blood contamination (OR = 28.63, 95% CI 6.67–162.44, 
P < 0.001) in a histological evaluation [23]. Remarkably, 
those good-quality tissue with less blood contamina-
tion was also achieved in our cases, as shown in Fig.  3. 
We also consider that the unique approach of making 
only three passes with rotation of the needle in the lesion 
Fig. 5 Histological findings for the diagnosis of AIP acquired by the 21-gauge Menghini-type needle with the rolling method. a Hematoxylin–Eosin 
(HE) staining shows marked lymphoplasmacytic infiltration and fibrosis in high-power fields (× 400). b IgG4 immunostaining shows abundant 
IgG4-positive cells (× 400). c HE staining shows storiform fibrosis with spindle-shaped cells and inflammatory cells (× 100). d, e HE and Elastica van 
Gieson staining show obstructive phlebitis with infiltration of inflammatory cells obstructing the vein (× 100)
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via the “rolling method” contributed to the acquisition 
of wrenched core tissue with relatively little blood con-
tamination, as with the liver biopsy technique using the 
Majima needle [25]. This method is based on the notion 
that a large amount of cored, good-quality tissue with lit-
tle contamination may be able to be acquired by reducing 
the number of strokes as much as possible. In addition, 
even the transduodenal approach resulted in sufficient 
tissue collection in all 16 patients [23] as well as in 1 
patient included in our study (100%), despite some rigid-
ity. Taken together, these results strongly support the 
notion that this 21-gauge Menghini-type biopsy needle 
with the rolling method can be a reliable way of obtaining 
abundant tissue with preserved architecture for a histo-
logical evaluation in order to make a diagnosis of AIP.
Another important role of EUS-FNA or EUS-FNB for 
patients with suspected AIP is the need to rule out the 
presence of malignancy. The accuracy of the cytologi-
cal evaluation has recently dramatically improved due to 
the advent of rapid onsite evaluation (ROSE) as well as 
the development of various needles and puncture tech-
niques, such as the fanning technique [39] and slow-pull 
technique [40]. In our study, cytological evaluations were 
consistently successful using both types of needles (93%: 
26/28). On the contrary, confirming adequate tissue 
acquisition for histological evaluations during EUS-FNB 
is usually difficult, because the obtained sample contains 
mucus, blood contamination, adipose tissue as well as 
required pancreatic tissue. As one of solution for over-
coming this issue, the identification of a macroscopic vis-
ible core which consisted of whitish or yellowish pieces 
contributed to a high acquisition rate of the histological 
core with a success rate of 87% (187/216) for all passes in 
the MOSE study [32]. Thus, the 21-gauge Menghini-type 
needle combined with the MOSE method can be a pow-
erful tool for confirming the histological diagnosis of AIP.
Two patients treated with a Menghini-type needle 
developed pancreatitis after the procedure. We generally 
performed EUS-FNB and subsequent ERCP in a single 
session, based on our previous findings, which demon-
strated the efficacy and safety of single-session EUS-
FNB and ERCP [29–31]. Minaga et  al. reported that no 
adverse event occurred in 47 patients with pancreatic 
masses treated with the Menghini-type needle [23]. On 
the other hand, Naito et al. reported that the incidence of 
post-ERCP pancreatitis was slightly lower in type 1 AIP 
than non-AIP cohort (1.2% vs. 5.8%, P = 0.119) [41]. The 
relation between this needle and pancreatitis cannot be 
referred to in this study, so further assessment is needed 
with more cases. Theoretically, the needle simply rotates 
in the pancreas using the additional “rolling method”. 
Therefore, bleeding can be considered an alarming risk 
associated with this method, especially if adequate core 
tissue is acquired from pancreas. Fortunately, no bleed-
ing occurred in any of our cases. However, further assess-
ments in more cases will be needed to confirm the safety.
On reviewing the previous reports described in Table 3, 
the utility of some FNB needles, such as the Franseen 
type (Acquire) and fork-tip type needles (SharkCore), 
has recently been reported for the diagnosis of AIP. 
These needles seemed to contribute to a good histo-
logical assessment for diagnosing AIP. Interestingly, the 
Menghini-type needle with the rolling method is unlikely 
to be inferior to these FNB needles. In addition, one spe-
cific merit of this procedure is that even a few strokes can 
provide a substantial amount of good-quality tissue. This 
merit will prove particularly beneficial for lesions that are 
not easy to puncture due to the scope position, helping to 
improve the diagnostic ability. However, which needle is 
the best remains unclear, and a randomized control study 
will be needed to clarify this point.
Several limitations associated with the present study 
warrant mention. First, this was a retrospective, single-
center study with a small number of enrolled patients. 
However, the amount of specimen acquired by the 
Menghini-type needle with the rolling method was quite 
large, as shown in Figs. 2 and 3. In addition, in the two 
patients treated with both needles, a substantial amount 
of tissue was acquired by the Menghini-type needle with 
the rolling method, while relatively little tissue had been 
acquired with the previously used conventional-type 
needle, as shown in Fig. 4. Second, we evaluated patients 
treated with 22-gauge conventional-type needles as his-
torical controls, and the needles were selected based on 
the two experts’ preference. In addition, these patients 
were characterized by segmental or focal enlargement of 
the pancreas, the adoption of a transduodenal approach 
for EUS, and a low number of punctures, which may 
have resulted in worse outcomes for these patients than 
for others in the present and previous studies. However, 
even though several prospective studies conducted in 
academic institutions with expert pathologists showed 
excellent outcomes using 22-gauge FNA needles for the 
diagnosis of AIP [17–19, 21], the diagnostic rate, propor-
tion of Level 1 or 2 in ICDC and positive rates of spe-
cific histological findings differed markedly between 
these studies. In reality, the biopsy-based diagnosis of 
AIP is challenging and remains unstandardized. Just 
recently, Notohara et al. advocated guidance for diagnos-
ing AIP with biopsy tissue in order to standardize pathol-
ogy reports of pancreatic biopsies for diagnosing type 1 
AIP [42]. These differences in results are also consistent 
with a previous study, wherein small samples obtained 
by EUS-FNA induced low diagnostic agreement among 
pathologists from not only academic institutions but also 
non-academic institutions [43]. Although the acquired 
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sample area has not been evaluated in the prospective 
studies, we believe that their superb outcomes are not 
necessarily adapted in all institutions around the world. 
Third, the patients in each group underwent different 
biopsy techniques, whether the rolling method or the 
standard aspiration technique. This means that this study 
was not a pure comparison of both needles. We empha-
size that the utility of the 21-gauge Menghini-type needle 
combined with the rolling method was superior to that 
of the conventional 22-gauge needle with the standard 
aspiration technique in terms of the amount of acquired 
tissue. However, we cannot state whether the needle or 
technique had a greater effect on the amount of tissue 
acquired in this study. To clarify this point, a randomized 
control study comparing the 21-gauge Menghini-type 
needle with and without the rolling method will need to 
be conducted. Fourth, all patients were type 1 AIP, so the 
performance of the Menghini-type needle for the diagno-
sis of type 2 AIP remains unclear.
Despite these limitations, however, our study demon-
strated that the outcomes in patients treated with the 
Menghini-type needle with the rolling method were 
undoubtedly preferable to the outcomes in patients 
treated with other approaches, as proven by the objective 
evaluation of the acquired tissue area. This superiority is 
attributed to the ability to acquire an abundant amount 
of tissue, which was exactly important for obtaining a 
histological diagnosis of AIP [22]. In addition, we empha-
size that histology of larger sample would contribute to 
strengthened diagnostic performance and agreement 
among pathologists of varying expertise. However, fur-
ther study is needed to be validated in a large number of 
AIP patients.
In conclusion, the 21-gauge Menghini-type biopsy nee-
dle with the rolling method is useful for the EUS-guided 
histopathological diagnosis of AIP due to its abundant 
acquisition of good-quality tissue from the pancreas. It 
will significantly aid in the definitive diagnosis of AIP.
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